Follow-up: Indivior ceases marketing of controversial overdose reversal drug – The Shoestring
The Shoestring and NEPM previously reported on a dubious claim in marketing emails sent to local police departments. Now, the company has settled with New York’s attorney general over allegations of “misleading promotion.”| The Shoestring
